Cerus CERS
NASDAQ CERS
$2.51 -0.03 (-1.18%)
As of: Sep 9, 2026 · 3:59 PM EDT

Cerus (CERS) Cash from Financing Activities (2010 - 2026)

Cerus' (CERS) quarterly Cash from Financing Activities came in at -$20.0 million in Q2 2026, down 15434.11% year-over-year from N/an in Q2 2025, and down 1781.12% quarter-over-quarter from $1.2 million in Q1 2026.

Analysis

Cerus (CERS) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Cerus has disclosed Cash from Financing Activities across 17 years of filings, most recently posting -$20.0 million for Q2 2026.

  • In Q2 2026, Cash from Financing Activities fell 15434.11% year-over-year to -$20.0 million; the TTM figure through Jun 2026 stood at -$19.6 million (down 1218.88% YoY), while the FY2025 annual figure was $231000.0, down 95.35% from the prior year.
  • Cash from Financing Activities came in at -$20.0 million for Q2 2026 at Cerus, down from $1.2 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $7.6 million in Q3 2023 to a low of -$20.0 million in Q2 2026.
  • Average Cash from Financing Activities over 5 years is $67388.9, with a median of $601500.0 recorded in 2022.
  • Year-over-year, Cash from Financing Activities surged 601.29% in 2023 and plunged 15434.11% in 2026.
  • Over 5 years, Cash from Financing Activities stood at $457000.0 in 2022, then soared by 158.86% to $1.2 million in 2023, then sank by 36.94% to $746000.0 in 2024, then slumped by 238.2% to -$1.0 million in 2025, then tumbled by 1843.65% to -$20.0 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$20.0 million in Q2 2026, $1.2 million in Q1 2026, and -$1.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -287.90 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -343.00 Mn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -300,000.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -510.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -607.30 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -213.50 Mn
10 Cerus 504.42 Mn 448.16 Mn 29.53 Mn -20.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.04 Mn
Mar 31, 2026 1.19 Mn
Dec 31, 2025 -1.03 Mn
Sep 30, 2025 320,000.00
Jun 30, 2025 -129,000.00
Mar 31, 2025 1.07 Mn
Dec 31, 2024 746,000.00
Sep 30, 2024 60,000.00
Jun 30, 2024 -1.40 Mn
Mar 31, 2024 5.56 Mn
Dec 31, 2023 1.18 Mn
Sep 30, 2023 7.60 Mn
Jun 30, 2023 -173,000.00
Mar 31, 2023 2.06 Mn
Dec 31, 2022 457,000.00
Sep 30, 2022 1.08 Mn
Jun 30, 2022 202,000.00
Mar 31, 2022 2.45 Mn
Dec 31, 2021 12.10 Mn
Sep 30, 2021 4.58 Mn